BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 237 found
  Current Search:  pseudomonas: 237     

HTML
100%
High Inoculum Pseudomonas aeruginosa Attenuates Colistin Bactericidal Activity Characterized by a New Mechanism-based Population Pharmacodynamic Model [Article]
High Inoculum Pseudomonas aeruginosa Attenuates Colistin Bactericidal Activity Characterized by a New Mechanism-based Population Pharmacodynamic Model Jrgen B.

Bulitta*, Jenny C.

Yang, Liliana Yohonn, Neang S.

Ly, Silvia V.

Brown, Rebecca E.

D...

AAC:  Mar 20 2010 2:05AM
Matching: pseudomonas
Find similar documents
HTML
100%
Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion [Article]
Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion Daniel Aiello, John D.

Williams, Helena Majgier-Baranowska, Ishan Patel, Norton P.

Peet, Jin Huang, Stephen Lory, Terry L.

Bowlin, and Donald T.

Moir*...

AAC:  Mar 20 2010 2:06AM
Matching: pseudomonas
Find similar documents
HTML
100%
Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Pseudomonas Pneumonia [Article]
Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Pseudomonas Pneumonia David J.

Feola*, Beth A.

Garvy, Theodore J.

Cory, Susan E.

Birket, Heather Hoy, Don Hayes Jr., and Brian S.

Murphy Departments of Pharmacy...

AAC:  Mar 20 2010 2:04AM
Matching: pseudomonas
Find similar documents
HTML
100%
Efflux Pumps, OprD Porin, AmpC {beta}-Lactamase and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis [Article]
Expression of ampC, oprD , mexA , mexC , mexE , and mexX was studied in 25 Pseudomonas aeruginosa from cystic fibrosis patients, including 14 isolates of the Liverpool epidemic strain.

Overexpressed mexA or ampC and reduced oprD were associated with ...

AAC:  Mar 20 2010 2:06AM
Matching: pseudomonas
Find similar documents
HTML
100%
Garlic as an inhibitor of Pseudomonas aeruginosa quorum sensing in cystic fibrosis - a pilot randomized controlled trial
Pseudomonas aeruginosa forms biofilms in the cystic fibrosis lung.

Quorum sensing (QS) controls biofilm maturation, immune evasion, antibiotic tolerance and virulence factor production.

Garlic shows QS inhibitory activity in vitro and in animal models...

Pediatric Pulmonology:  Mar 20 2010 7:26AM
Matching: pseudomonas
Find similar documents
HTML
100%
FDA actions in brief, March 2010 (Iprivask, VPRIV, Mirapex ER, Cayston, Menveo, Lamictal XR, Rituxan, Oleptro,
Drugs and indications recently approved by the FDA Formulary Desirudin for injection (Iprivask, Canyon) was approved for the prevention of deep vein thrombosis.

Velaglucerase alfa for injection (VPRIV, Shire) was approved for the long-term treatment of type 1...

Formulary Journal:  Mar 20 2010 7:26AM
Matching: pseudomonas
Find similar documents
HTML
100%
Crystal Structure of the Narrow-Spectrum OXA-46 Class D {beta}-lactamase: Relationship between Active Site Lysine Carbamylation and Inhibition by Polycarboxylates [Article]
Crystal Structure of the Narrow-Spectrum OXA-46 Class D -lactamase: Relationship between Active Site Lysine Carbamylation and Inhibition by Polycarboxylates Jean-Denis Docquier, Manuela Benvenuti, Vito Calderone, Francesco Giuliani, Dimos Kapetis, Filomena De...
AAC:  Mar 20 2010 2:07AM
Matching: pseudomonas
Find similar documents
HTML
100%
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese
_ Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese.
Intl Journal of Antimicrobial Agents:  Mar 19 2010 10:45PM
Matching: pseudomonas
Find similar documents
HTML
100%
Potential of doripenem for the treatment of infections with multidrug-resistant Pseudomonas spp
_ Potential of doripenem for the treatment of infections with multidrug-resistant Pseudomonas spp.
Intl Journal of Antimicrobial Agents:  Mar 19 2010 10:45PM
Matching: pseudomonas
Find similar documents
HTML
100%
Tat Pathway-Mediated Translocation of the Sec Pathway Substrate Protein MexA, an Inner Membrane Component of t
Pseudomonas aeruginosa is equipped with the Sec and Tat protein secretion systems, which translocate the xenobiotic transporter MexAB-OprM and the pathogenic factor phospholipase C (PlcH), respectively.

When the signal sequence of MexA was replaced with...

AAC:  Mar 19 2010 6:29PM
Matching: pseudomonas
Find similar documents
HTML
100%
Penicillin Sulfone Inhibitors of Class D -Lactamases
OXA -lactamases are largely responsible for -lactam resistance in Acinetobacter spp.

and Pseudomonas aeruginosa, two of the most difficult-to-treat nosocomial pathogens.

In general, the -lactamase inhibitors used in clinical practice (clavulanic acid,...

AAC:  Mar 19 2010 6:28PM
Matching: pseudomonas
Find similar documents
HTML
100%
Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH
Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its new European subsidiary, Activeion (Europe) GmbH.

Activeion (Europe) GmbH will distribute and market the ionator EXP throughout Europe, the Middle East and Africa.

Activeion's ionator...

News-Medical.Net:  Mar 19 2010 1:18PM
Matching: pseudomonas
Find similar documents
HTML
100%
Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations
Fothergill JL et al.

The results of this study are indicative that significant fluctuations occur within P.

Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary...

MDLinx:  Mar 19 2010 10:06AM
Matching: pseudomonas
Find similar documents
HTML
100%
The epidemiology of recurrent Gram-negative bacteremia in a tertiary-care hospital
were reviewed for microbial etiology and susceptibilities.

Patient charts were reviewed to determine the source of infection and outcome.

Results Forty-five nosocomial Gram-negative bacteremias occurred in 44 patients.

Infection rates of 6.9/1000...

DiagnosticMicrobiology and Infectious Disease:  Mar 18 2010 7:26PM
Matching: pseudomonas
Find similar documents
HTML
100%
In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for diabetic foot infections
Petersen PJ et al.

Pseudomonas aeruginosa and several pathogens in the Proteeae group were generally less susceptible to tigecycline by comparison to other Gramnegative pathogens.

In vitro activity of tigecycline against patient isolates collected...

MDLinx:  Mar 17 2010 11:58AM
Matching: pseudomonas
Find similar documents
HTML
100%
Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Pseudomonas Pneumonia
David J.

Feola*, Beth A.

Garvy, Theodore J.

Cory, Susan E.

Birket, Heather Hoy, Don Hayes Jr., and Brian S.

Murphy Departments of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky 40536; Departments of...

AAC:  Mar 16 2010 11:12PM
Matching: pseudomonas
Find similar documents
HTML
100%
Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008
The study objective was to identify changes in cystic fibrosis (CF) sputum microbiology over 13 years.This study recruited a contemporary cohort of CF patients meeting similar eligibility criteria as the 520 subjects in the Phase 3 trials of inhaled tobramycin ...
Pediatric Pulmonology:  Mar 16 2010 11:48AM
Matching: pseudomonas
Find similar documents
HTML
100%
Targeted antibiotics tackle bacterial resistance
Antibiotic resistance is increasing to such a level that there are fears that within 20 years antibiotics will cease to function, an eventuality that could take us back to the days before penicillin.

Compounds that block the bacteria's pathogenicity instead...

Australian Life Scientist:  Mar 16 2010 5:11AM
Matching: pseudomonas
Find similar documents
HTML
100%
Bayer obtains FDA orphan drug designation for cystic fibrosis drug
Bayer HealthCare Pharmaceuticals has reported that an orphan drug designation has been granted by the FDA for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis, or CF, patients.
Datamonitor:  Mar 15 2010 9:21PM
Matching: pseudomonas
Find similar documents
HTML
100%
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxaci
Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S.

Food and Drug Administration (FDA) for ciprofloxacin dry powder inhaler (DPI) for management of pulmonary infection due to Pseudomonas...

PR-USA.net:  Mar 15 2010 1:57PM
Matching: pseudomonas
Find similar documents
HTML
100%
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis - Bayer Healthcare Pharmaceuticals
Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S.

Food and Drug Administration for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic...

MDLinx:  Mar 15 2010 11:01AM
Matching: pseudomonas
Find similar documents
HTML
100%
Persistent Pseudomonas Aeruginosa Infections in CF Patients Have Molecular Basis
Small Colony Variants (SCVs) of P.

aeruginosa to be a hallmark of chronic infection in cystic fibrosis (CF) patients, new research has revealed.

Results, published March 12th in the open-access journal PLoS Pathogens, suggest that SCV-mediated persistence...

MedIndia:  Mar 14 2010 1:59AM
Matching: pseudomonas
Find similar documents
HTML
100%
Molecular basis for Pseudomonas aeruginosa persistent infections in CF patients
New research reveals Small Colony Variants (SCVs) of P.

aeruginosa to be a hallmark of chronic infection in cystic fibrosis (CF) patients.

Results, published March 12th in the open-access journal PLoS Pathogens, suggest that SCV-mediated persistence might...

PhysOrg.com:  Mar 13 2010 10:24PM
Matching: pseudomonas
Find similar documents
HTML
100%
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powd
WAYNE, N.J., March 11 (HSMN NewsFeed) -- Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S.

Food and Drug Administration (FDA) for ciprofloxacin dry powder inhaler (DPI) for management of pulmonary...

Healthcare Sales & Marketing Network:  Mar 13 2010 5:30PM
Matching: pseudomonas
Find similar documents
HTML
100%
TU Delft improves production of chemicals from wood waste
They discovered that the bacterium Cupriavidus basilensis breaks down harmful by-products which are produced when sugars are released from wood.

They also managed to incorporate the degradation process in bacteria which are in common industrial use.

This...

Innovations Report:  Mar 13 2010 5:55AM
Matching: pseudomonas
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.